Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha-synuclein and Parkinson's disease.

Alessandra Recchia1, Patrizia Debetto, Alessandro Negro

  • 1Department of Pharmacology and Anesthesiology, University of Padova, 35131 Padova, Italy.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|April 1, 2004
PubMed
Summary

Alpha-synuclein (alpha-syn) dysfunction is central to Parkinson's disease (PD) pathogenesis. Understanding alpha-syn

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small Animal Veterinarians' Perceptions and Practices in Dog Aggression Prevention in Italy: A National Survey.

Animals : an open access journal from MDPI·2026
Same author

Dual Pathways Coupled to Oxytocin Molecular Signals in Cultured Astrocytes.

Cells·2026
Same author

Emerin is necessary for microtubule-organizing center translocation to the nuclear envelope of muscle cells.

Cell death & disease·2026
Same author

Longitudinal Myocardial Deformation Analysis of the Left Ventricle in Dogs with Leishmaniosis Investigated by Speckle-Tracking Echocardiography.

Pathogens (Basel, Switzerland)·2026
Same author

The medium-chain fatty acid octanoate is a beneficial fuel for the failing heart.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Serum amyloid A1 directly engages TLR4/MD-2 to trigger neuroinflammatory signaling in microglia cultures.

International immunopharmacology·2026

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Neurodegenerative Diseases

Background:

  • Alpha-synuclein (alpha-syn) is a presynaptic terminal protein implicated in neurodegenerative diseases.
  • Its physiological roles in membrane stability and neuronal plasticity are under investigation.
  • Alpha-syn dysfunction is a hallmark of Parkinson's disease (PD).

Purpose of the Study:

  • To explore the role of alpha-synuclein in the pathogenesis of Parkinson's disease.
  • To investigate the mechanisms underlying alpha-synuclein-induced neurotoxicity.
  • To evaluate the utility of alpha-synuclein-based models for studying PD.

Main Methods:

  • Review of existing literature on alpha-synuclein function and dysfunction.
  • Analysis of proposed pathways for alpha-synuclein-mediated neurotoxicity.

Related Experiment Videos

  • Evaluation of current animal models for Parkinson's disease.

    • Main Results:

    • Alpha-synuclein dysfunction, triggered by genetic or environmental factors, contributes to dopaminergic neuron loss in PD.
    • Multiple pathways, including aggregation and interactions with other molecules, mediate alpha-synuclein toxicity.
    • Alpha-synuclein-based animal models show promise for mimicking human PD pathology.

    Conclusions:

    • Alpha-synuclein dysfunction is a critical factor in Parkinson's disease.
    • The complex mechanisms of alpha-synuclein toxicity necessitate advanced research models.
    • Alpha-synuclein-based models offer the most relevant approach for studying PD.